313 related articles for article (PubMed ID: 21505342)
1. Hepatocellular carcinoma and liver transplantation.
Washburn K; Halff G
Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
[TBL] [Abstract][Full Text] [Related]
2. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.
Lee SG; Moon DB; Shin H; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
Transplant Proc; 2012 Mar; 44(2):520-2. PubMed ID: 22410060
[No Abstract] [Full Text] [Related]
4. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
[No Abstract] [Full Text] [Related]
5. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
[No Abstract] [Full Text] [Related]
6. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
[No Abstract] [Full Text] [Related]
7. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
8. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
[No Abstract] [Full Text] [Related]
9. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
Roayaie S; Llovet JM
Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
[TBL] [Abstract][Full Text] [Related]
10. Surgical options for hepatocellular carcinoma: resection and transplantation.
Olthoff KM
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S98-104. PubMed ID: 9742501
[TBL] [Abstract][Full Text] [Related]
11. Current controversies surrounding liver transplantation for hepatocellular carcinoma.
Silva MF; Wigg AJ
J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247
[TBL] [Abstract][Full Text] [Related]
12. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
Jonas S; Mittler J; Pascher A; Schumacher G; Theruvath T; Benckert C; Rudolph B; Neuhaus P
Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait?
Mizuno S; Yokoi H; Shiraki K; Usui M; Sakurai H; Tabata M; Sugimoto K; Takei Y; Yamakado K; Takeda K; Uemoto S; Isaji S
Transplantation; 2010 Mar; 89(6):650-4. PubMed ID: 20048691
[TBL] [Abstract][Full Text] [Related]
15. Selection of candidates with HCC for transplantation in the MELD era.
Sala M; Varela M; Bruix J
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
[TBL] [Abstract][Full Text] [Related]
16. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
[TBL] [Abstract][Full Text] [Related]
17. [Selection criteria decisive in hepatocellular carcinoma].
Söderdahl G; Eilard MS; Rizell M
Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
[No Abstract] [Full Text] [Related]
18. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
19. Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment.
Schmidt C; Marsh JW
Curr Opin Organ Transplant; 2010 Jun; 15(3):277-82. PubMed ID: 20414113
[TBL] [Abstract][Full Text] [Related]
20. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
Ito T; Takada Y; Ueda M; Haga H; Maetani Y; Oike F; Ogawa K; Sakamoto S; Ogura Y; Egawa H; Tanaka K; Uemoto S
Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
